{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:15:47Z","timestamp":1780582547205,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Elevated angiotensin-converting enzyme 2 (ACE2) expression in organs that are potential targets of severe acute respiratory syndrome coronavirus 2 may increase the risk of coronavirus disease 2019 (COVID-19) infection. Previous reports show that ACE2 alter its tissue-specific expression patterns under various pathological conditions, including renal diseases. Here, we examined changes in pulmonary ACE2 expression in two mouse chronic kidney disease (CKD) models: adenine-induced (adenine mice) and aristolochic acid-induced (AA mice). We also investigated changes in pulmonary ACE2 expression due to renin\u2013angiotensin system (RAS) blocker (olmesartan) treatment in these mice. Adenine mice showed significant renal functional decline and elevated blood pressure, compared with controls. AA mice also showed significant renal functional decline, compared with vehicles; blood pressure did not differ between groups. Renal ACE2 expression was significantly reduced in adenine mice and AA mice; pulmonary expression was unaffected. Olmesartan attenuated urinary albumin excretion in adenine mice, but did not affect renal or pulmonary ACE2 expression levels. The results suggest that the risk of COVID-19 infection may not be elevated in patients with CKD because of their stable pulmonary ACE2 expression. Moreover, RAS blockers can be used safely in treatment of COVID-19 patients with CKD.<\/jats:p>","DOI":"10.1038\/s41598-021-96294-8","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:30:05Z","timestamp":1629369005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Shunichiro","family":"Tsukamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Azushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Urate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Kinguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"96294_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"96294_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"96294_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ. Res. 87, E1-9 (2000).","journal-title":"Circ. Res."},{"key":"96294_CR4","doi-asserted-by":"publisher","first-page":"v207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","volume":"55","author":"AJ Ferreira","year":"2010","unstructured":"Ferreira, A. J. et al. Therapeutic implications of the vasoprotective axis of the renin\u2013angiotensin system in cardiovascular diseases. Hypertension 55, v207-213 (2010).","journal-title":"Hypertension"},{"key":"96294_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MNH.0b013e3280123c0e","volume":"16","author":"KD Burns","year":"2007","unstructured":"Burns, K. D. The emerging role of angiotensin-converting enzyme-2 in the kidney. Curr. Opin. Nephrol. Hypertens. 16, 116\u2013121 (2007).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"96294_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai, Y. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112\u2013116 (2005).","journal-title":"Nature"},{"key":"96294_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11906-020-1028-6","volume":"22","author":"K Azushima","year":"2020","unstructured":"Azushima, K., Morisawa, N., Tamura, K. & Nishiyama, A. Recent research advances in renin\u2013angiotensin\u2013aldosterone system receptors. Curr. Hypertens. Rep. 22, 22 (2020).","journal-title":"Curr. Hypertens. Rep."},{"key":"96294_CR8","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1681\/ASN.2006050423","volume":"17","author":"M Ye","year":"2006","unstructured":"Ye, M. et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067\u20133075 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"96294_CR9","doi-asserted-by":"publisher","first-page":"c57","DOI":"10.1159\/000319648","volume":"117","author":"S Mizuiri","year":"2011","unstructured":"Mizuiri, S. et al. Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy. Nephron Clin. Pract. 117, c57\u2013c66 (2011).","journal-title":"Nephron Clin. Pract."},{"key":"96294_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/CS20090318","volume":"118","author":"E Velkoska","year":"2010","unstructured":"Velkoska, E., Dean, R. G., Burchill, L., Levidiotis, V. & Burrell, L. M. Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition. Clin. Sci. (Lond.). 118, 269\u2013279 (2010).","journal-title":"Clin. Sci. (Lond.)."},{"key":"96294_CR11","doi-asserted-by":"publisher","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand, J., Patel, S. K., Srivastava, P. M., Farouque, O. & Burrell, L. M. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE 13, e0198144 (2018).","journal-title":"PLoS ONE"},{"key":"96294_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","volume":"43","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock 43, 395\u2013404 (2015).","journal-title":"Shock"},{"key":"96294_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14003","author":"PAB Wark","year":"2021","unstructured":"Wark, P. A. B. et al. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology https:\/\/doi.org\/10.1111\/resp.14003 (2021).","journal-title":"Respirology"},{"key":"96294_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2020.05.013","volume":"18","author":"N Saheb Sharif-Askari","year":"2020","unstructured":"Saheb Sharif-Askari, N. et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol. Ther. Methods Clin. Dev. 18, 1\u20136 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"96294_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/07853890.2020.1790643","volume":"52","author":"SK Kunutsor","year":"2020","unstructured":"Kunutsor, S. K. & Laukkanen, J. A. Renal complications in COVID-19: A systematic review and meta-analysis. Ann. Med. 52, 345\u2013353 (2020).","journal-title":"Ann. Med."},{"key":"96294_CR16","doi-asserted-by":"publisher","first-page":"101825","DOI":"10.1016\/j.tmaid.2020.101825","volume":"37","author":"CR Jutzeler","year":"2020","unstructured":"Jutzeler, C.R. et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 37, 101825 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"96294_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.dsx.2020.06.064","volume":"14","author":"K Nandy","year":"2020","unstructured":"Nandy, K. et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab. Syndr. 14, 1017\u20131025 (2020).","journal-title":"Diabetes Metab. Syndr."},{"key":"96294_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"96294_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 323, 2052\u20132059 (2020).","journal-title":"JAMA"},{"key":"96294_CR20","unstructured":"Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2019. US Department of Health and Human Services, Centers for Disease Control and Prevention, (2019)."},{"issue":"20","key":"96294_CR21","first-page":"30637","volume":"S0196\u20136553","author":"KT Bajgain","year":"2020","unstructured":"Bajgain, K. T., Badal, S., Bajgain, B. B. & Santana, M. J. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am. J. Infect. Control S0196\u20136553(20), 30637\u201330644 (2020).","journal-title":"Am. J. Infect. Control"},{"key":"96294_CR22","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"HP Jia","year":"2005","unstructured":"Jia, H. P. et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79, 14614\u201314621 (2005).","journal-title":"J. Virol."},{"key":"96294_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamapediatrics.2020.4573","volume":"175","author":"RM Viner","year":"2021","unstructured":"Viner, R. M. et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: A systematic review and meta-analysis. JAMA Pediatr. 175, 143\u2013156 (2021).","journal-title":"JAMA Pediatr."},{"key":"96294_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","volume":"225","author":"RM W\u00f6sten-van Asperen","year":"2011","unstructured":"W\u00f6sten-van Asperen, R. M. et al. Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist. J. Pathol. 225, 618\u2013627 (2011).","journal-title":"J Pathol."},{"key":"96294_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/hr.2014.49","volume":"37","author":"J Iwanami","year":"2014","unstructured":"Iwanami, J. et al. Role of angiotensin-converting enzyme 2\/ angiotensin-(1\u20137)\/Mas axis in the hypotensive effect of azilsartan. Hypertens. Res. 37, 616\u2013620 (2014).","journal-title":"Hypertens. Res."},{"key":"96294_CR26","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","volume":"296","author":"MJ Soler","year":"2009","unstructured":"Soler, M. J. et al. Localization of ACE2 in the renal vasculature: Amplification by angiotensin II type 1 receptor blockade using telmisartan. Am. J. Physiol. Ren. Physiol. 296, F398\u2013F405 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"96294_CR27","doi-asserted-by":"publisher","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","volume":"298","author":"M Dilauro","year":"2010","unstructured":"Dilauro, M., Zimpelmann, J., Robertson, S. J., Genest, D. & Burns, K. D. Effect of ACE2 and angiotensin-(1\u20137) in a mouse model of early chronic kidney disease. Am. J. Physiol. Ren. Physiol. 298, F1523\u2013F1532 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"96294_CR28","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/jmv.26588","volume":"93","author":"Y Yokoyama","year":"2021","unstructured":"Yokoyama, Y., Aikawa, T., Takagi, H., Briasoulis, A. & Kuno, T. Association of renin\u2013angiotensin\u2013aldosterone system inhibitors with mortality and testing positive of COVID-19: Meta-analysis. J. Med. Virol. 93, 2084\u20132089 (2021).","journal-title":"J. Med. Virol."},{"key":"96294_CR29","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds, H. R. et al. Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19. N. Engl. J. Med. 382, 2441\u20132448 (2020).","journal-title":"N. Engl. J. Med."},{"key":"96294_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","volume":"314","author":"MP N\u00e4gele","year":"2020","unstructured":"N\u00e4gele, M. P., Haubner, B., Tanner, F. C., Ruschitzka, F. & Flammer, A. J. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis 314, 58\u201362 (2020).","journal-title":"Atherosclerosis"},{"key":"96294_CR31","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2020050667","volume":"31","author":"J Wysocki","year":"2020","unstructured":"Wysocki, J., Lores, E., Ye, M., Soler, M. J. & Batlle, D. Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: Implications for COVID-19. J. Am. Soc. Nephrol. 31, 1941\u20131943 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"96294_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2353\/ajpath.2009.080511","volume":"174","author":"T Tanaka","year":"2009","unstructured":"Tanaka, T. et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am. J. Pathol. 174, 1203\u20131211 (2009).","journal-title":"Am. J. Pathol."},{"key":"96294_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.07.020","volume":"161","author":"MK Mazumder","year":"2016","unstructured":"Mazumder, M. K., Giri, A., Kumar, S. & Borah, A. A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci. 161, 27\u201336 (2016).","journal-title":"Life Sci."},{"key":"96294_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.ki.5002714","volume":"73","author":"AA Pozdzik","year":"2008","unstructured":"Pozdzik, A. A. et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73, 595\u2013607 (2008).","journal-title":"Kidney Int."},{"key":"96294_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.kint.2019.09.032","volume":"97","author":"H Motohashi","year":"2020","unstructured":"Motohashi, H. et al. The circadian clock is disrupted in mice with adenine-induced tubulointerstitial nephropathy. Kidney Int. 97, 728\u2013740 (2020).","journal-title":"Kidney Int."},{"key":"96294_CR36","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/j.1523-1755.2004.00905.x","volume":"66","author":"FD Debelle","year":"2004","unstructured":"Debelle, F. D. et al. The renin\u2013angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int. 66, 1815\u20131825 (2004).","journal-title":"Kidney Int."},{"key":"96294_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20130420","volume":"127","author":"DW Lambert","year":"2014","unstructured":"Lambert, D. W. et al. Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421. Clin. Sci. (Lond.) 127, 243\u2013249 (2014).","journal-title":"Clin. Sci. (Lond.)"},{"key":"96294_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000493805","volume":"141","author":"B Trojanowicz","year":"2019","unstructured":"Trojanowicz, B. et al. Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease. Nephron 141, 61\u201374 (2019).","journal-title":"Nephron"},{"key":"96294_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/epi-2020-0247","volume":"13","author":"AA Braga","year":"2021","unstructured":"Braga, A. A. et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics 13, 423\u2013436 (2021).","journal-title":"Epigenomics"},{"key":"96294_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel, V. B. et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: A positive feedback mechanism in the RAS. J. Mol. Cell. Cardiol. 66, 167\u2013176 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"96294_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/CS20201511","volume":"135","author":"MA Pedrosa","year":"2021","unstructured":"Pedrosa, M. A. et al. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19. Clin. Sci. (Lond.). 135, 465\u2013481 (2021).","journal-title":"Clin. Sci. (Lond.)."},{"key":"96294_CR42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/HYPERTENSIONAHA.108.117341","volume":"52","author":"A Shigenaga","year":"2008","unstructured":"Shigenaga, A. et al. Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension 52, 672\u2013678 (2008).","journal-title":"Hypertension"},{"key":"96294_CR43","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1038\/s41598-019-42657-1","volume":"9","author":"K Azushima","year":"2019","unstructured":"Azushima, K. et al. Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice. Sci. Rep. 9, 6201 (2019).","journal-title":"Sci. Rep."},{"key":"96294_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/HYPERTENSIONAHA.109.147207","volume":"55","author":"H Wakui","year":"2010","unstructured":"Wakui, H. et al. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 55, 1157\u20131164 (2010).","journal-title":"Hypertension"},{"key":"96294_CR45","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/s41598-018-21270-8","volume":"8","author":"K Ohki","year":"2018","unstructured":"Ohki, K. et al. Angiotensin II type 1 receptor-associated protein inhibits angiotensin ii-induced insulin resistance with suppression of oxidative stress in skeletal muscle tissue. Sci. Rep. 8, 2846 (2018).","journal-title":"Sci. Rep."},{"key":"96294_CR46","doi-asserted-by":"publisher","first-page":"e004488","DOI":"10.1161\/JAHA.116.004488","volume":"6","author":"K Azushima","year":"2017","unstructured":"Azushima, K. et al. Adipocyte-specific enhancement of angiotensin II type 1 receptor-associated protein ameliorates diet-induced visceral obesity and insulin resistance. J. Am. Heart Assoc. 6, e004488 (2017).","journal-title":"J. Am. Heart Assoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96294-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96294-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96294-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:53:41Z","timestamp":1670072021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96294-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96294-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16843"}}